---
title: "KANTOFF AARON — Ownership Dossier"
canonical: https://whiteintel.dev/entity/81fd7dd3-16a0-5de9-8d6d-306a413e080d
json: https://whiteintel.dev/api/public/dossier/81fd7dd3-16a0-5de9-8d6d-306a413e080d
identifier: sec:0001862734
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# KANTOFF AARON

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001862734`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/81fd7dd3-16a0-5de9-8d6d-306a413e080d  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/81fd7dd3-16a0-5de9-8d6d-306a413e080d  

## Ownership & control

### Holdings / subsidiaries

- **Avalo Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/7ab53ad5-4202-5e5d-afb7-054c499320ac
- **Tourmaline Bio, Inc.** (director) — https://whiteintel.dev/entity/e1b4b063-4f99-531b-96ca-e789eae5eefb
- **Centessa Pharmaceuticals plc** (director) — https://whiteintel.dev/entity/8043a488-3895-5c19-b9a5-372a51ca41d8

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **KANTOFF AARON**. Human view: https://whiteintel.dev/entity/81fd7dd3-16a0-5de9-8d6d-306a413e080d · Structured JSON: https://whiteintel.dev/api/public/dossier/81fd7dd3-16a0-5de9-8d6d-306a413e080d._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._